Harrow Inc (HROW)

21.60 +0.76 (+3.62%) USD  |  NASDAQ  |  Jul 03, 16:00
More

Harrow Research and Development Expense (TTM): 8.067M for March 31, 2024

Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2008. Upgrade now.
Date Value
March 31, 2024 8.067M
December 31, 2023 6.652M
September 30, 2023 4.019M
June 30, 2023 3.373M
March 31, 2023 3.126M
December 31, 2022 3.05M
September 30, 2022 6.289M
June 30, 2022 11.64M
March 31, 2022 11.15M
December 31, 2021 11.08M
September 30, 2021 7.733M
June 30, 2021 2.278M
March 31, 2021 2.602M
December 31, 2020 2.413M
September 30, 2020 2.246M
June 30, 2020 2.02M
March 31, 2020 2.081M
December 31, 2019 2.083M
September 30, 2019 2.092M
June 30, 2019 1.881M
March 31, 2019 1.143M
December 31, 2018 0.825M
September 30, 2018 0.481M
June 30, 2018 0.311M
March 31, 2018 0.34M
Date Value
December 31, 2017 0.413M
September 30, 2017 0.925M
June 30, 2017 0.878M
March 31, 2017 0.853M
December 31, 2016 0.739M
September 30, 2016 0.171M
June 30, 2016 0.248M
March 31, 2016 0.197M
December 31, 2015 0.332M
September 30, 2015 0.37M
June 30, 2015 0.347M
March 31, 2015 0.358M
December 31, 2014 0.237M
September 30, 2014 0.1802M
June 30, 2014 0.5796M
March 31, 2014 1.221M
December 31, 2013 1.616M
September 30, 2013 2.320M
June 30, 2013 2.154M
March 31, 2013 1.611M
December 31, 2012 1.298M
September 30, 2012 0.5802M
June 30, 2012 0.2766M
March 31, 2012 0.1673M
December 31, 2011 0.1116M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

2.02M
Minimum
Jun 2020
11.64M
Maximum
Jun 2022
4.947M
Average
3.126M
Median
Mar 2023

Research and Development Expense (TTM) Benchmarks

Durect Corp 24.88M
Stereotaxis Inc 9.77M
Cara Therapeutics Inc 106.14M
Voyager Therapeutics Inc 100.70M
Journey Medical Corp 13.39M